An Innovative Unbound Bilirubin Assay to Identify Bilirubin-Induced Neurological Dysfunction (BIND) Risk as Part of a Comprehensive and Novel Point-of-Care Newborn Screening Panel
IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
-
Activity
R44
-
Administering IC
HL
-
Application Type
5
-
Direct Cost Amount
-
Indirect Cost Amount
-
Total Cost
681054
-
Sub Project Total Cost
-
ARRA Funded
False
-
CFDA Code
839
-
Ed Inst. Type
-
Funding ICs
NHLBI:681054\
-
Funding Mechanism
SBIR-STTR RPGs
-
Study Section
ZRG1
-
Study Section Name
Special Emphasis Panel